Dear All, Launched in 2016, the Antimicrobial Stewardship Program (ASP) at the Center for Infectious Disease Research and Policy (CIDRAP) of the University of Minnesota
Dear All, WHO have opened a call for experts to be part of an Advisory Group on their Critically Important Antimicrobial (CIA) List. Background: As
Dear All, I’ve previously written about the AMR Action Fund (9 Jul 2020 newsletter), a $1b fund created by 20+ global pharma with the intertwined
COVID-related heads-up: FDA has announced that VRBPAC (Vaccines and Related Biological Products Advisory Committee) will meet on 10 Dec 2020 to discuss the Pfizer-BioNTech COVID-19
Dear All, The G20’s Global AMR R&D Hub (https://globalamrhub.org/, see below my signature for a brief history of the Hub) has a job opening from
Dear All, First up today is a very interesting new workshop from FDA on 1-2 Sep entitled “Advancing the Development of Pediatric Therapeutics (ADEPT 7) Complex
Dear All, See below my signature: A 6-month consultancy with WHO to support the the SECURE initiative, a program to assist countries in accessing and sustainably
Dear All, The Wellcome Trust Drug-Resistant Infections team wants to understand what researchers in academia and SMEs need to enable them to be better able
Dear All, Quick note today as I am both exhausted and exhilarated by having listened to the all-day FDA Advisory committee on the Pfizer/BioNTech COVID
Dear All, As you know, WHO has been driving a series of clinical and preclinical pipeline reviews (go here for my current master list of